Evaluate the Effectiveness of the Mobile Instant Messaging Intervention
Exploring the Care Needs of Spouses of Gynecological Cancer Patients and Evaluating the Development of Care Plans
1 other identifier
interventional
70
1 country
1
Brief Summary
This study explores the caregiving needs of male spouses and develops an instant messaging software intervention to provide effective support. The goal is to help male spouses better adjust to their caregiving roles, reduce psychological stress and emotional distress, and improve overall health. A randomized controlled trial will be conducted to evaluate the effectiveness of the mobile instant messaging intervention, analyzing its impact on reducing psychological distress and improving the quality of life of male spouses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2025
CompletedFirst Posted
Study publicly available on registry
April 29, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2028
April 29, 2025
April 1, 2025
3 years
April 21, 2025
April 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Supportive Care Needs -Partners & Caregivers 45, SCNS-P&C45
Post-intervention assessments will be conducted at 1 month, 3 months, and 6 months after the intervention.
Study Arms (2)
instant messaging software
EXPERIMENTAL"Control Group"
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Age 18 or older, with a diagnosis of gynecological cancer (including cancers of the cervix, endometrium, fallopian tubes, ovaries, uterus, or vagina), and whose spouse has not been diagnosed with any other type of cancer;
- The spouse has undergone cancer treatment, including surgery, chemotherapy, or radiotherapy;
- Clear consciousness and ability to communicate in Mandarin or Taiwanese;
- Willingness to participate in the study after being informed of the study purpose and procedures.
You may not qualify if:
- Individuals with psychiatric disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shin Kong Memorial Wu Ho-Su Hospital
Taipei, 111, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished Professor & Dean, College of Nursing
Study Record Dates
First Submitted
April 21, 2025
First Posted
April 29, 2025
Study Start
August 1, 2025
Primary Completion (Estimated)
July 31, 2028
Study Completion (Estimated)
July 31, 2028
Last Updated
April 29, 2025
Record last verified: 2025-04